about
Airway smooth muscle in asthma: just a target for bronchodilation?Nasal airway epithelial cell IL-6 and FKBP51 gene expression and steroid sensitivity in asthmatic children.Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4DIn vivo micro-CT assessment of airway remodeling in a flexible OVA-sensitized murine model of asthma.Protease activated receptor-2 expression and function in asthmatic bronchial smooth muscleAn age-wise comparison of human airway smooth muscle proliferative capacity.House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway.Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients.Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthmaLongitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.Bronchial measurements in patients with asthma: comparison of quantitative thin-section CT findings with those in healthy subjects and correlation with pathologic findings.Pathophysiology of bronchial smooth muscle remodelling in asthma.Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.The pivotal role of airway smooth muscle in asthma pathophysiologyIn Vivo Computed Tomography as a Research Tool to Investigate Asthma and COPD: Where Do We Stand?Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis.Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6Identification of Airway-Mucosal Type-2 inflammation by Clinical Biomarkers in Asthma.Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy.Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6.Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma.Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study.Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration.Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway.Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells.Heme oxygenase inhibits human airway smooth muscle proliferation via a bilirubin-dependent modulation of ERK1/2 phosphorylation.Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma.The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.CT attenuation of the bronchial wall in patients with asthma: comparison with geometric parameters and correlation with function and histologic characteristics.Bronchial morphometry in smokers: comparison with healthy subjects by using 3D CT.Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.Chymase-positive mast cells: a double-edged sword in asthma?RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells.Increased secretion of leukemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signaling and airway contractility.Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.Case-Finding for Persistent Airway Obstruction in Farmers: A Questionnaire With Optimal Diagnosis Criteria.Bronchial Smooth Muscle Remodeling in Nonsevere Asthma.A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.
P50
Q27023298-E9D74A44-315F-4AAC-941C-362882F3888CQ33663854-7CBCFC98-C9CC-46AE-8C72-002CEFC216A0Q33670161-5EB08618-FE15-42FE-BA5E-48E88B206227Q33911113-48FC425E-57D1-4A98-ACD8-906C3F7B796DQ34465187-185C550B-627C-4102-8677-78BAF17A372EQ35097228-7814E485-5A57-45E5-8CDF-24410B03397FQ35208777-91109490-1EA2-41BB-ADCB-3AB48CB92476Q35540111-5D3408CA-0461-47A6-8251-0FAC68CA3830Q35873967-F87D7439-41CD-4FCA-A2B0-9F82E3F3C992Q36292443-3248B6EB-54F7-439B-9E2D-CC67762CECC3Q36294362-0DC68174-8850-4AAB-9BB1-95ADFF53A6F0Q36828893-82A66070-8B35-466D-B7F8-16BF7690C340Q37605375-67474A59-CCC9-49C3-B3D9-8E563AA80CEEQ37805298-B6FEBF60-140B-44D3-BF59-E54236C04B85Q37844892-B82C7962-EAC0-4E14-8965-8742E78C3CBAQ37973343-7172817A-7EED-4FB2-8C33-B603E771DD5DQ37979791-00E007D8-6666-4386-8FB9-2D0286B81C7DQ38771516-719F808B-7DE6-4402-92CC-D76CB7C22C06Q38837093-46C60921-ABF1-47E6-8D45-AE44090FB88BQ39019426-2F3C18B4-58E3-4845-A054-1307B20CF157Q39268815-D5003144-6535-4B71-BBD3-DB6C0AC7F934Q39745453-7025296B-1FAE-4547-B77F-D71BD620D8CDQ40327330-76DF3581-42A0-4BCE-8B4C-93CD219AEDF5Q40446627-73F18E06-FAA0-4B26-BE05-F7D7D0CA4F05Q40465033-0E76572F-A932-4A81-A0D5-32A8E35F8505Q41100576-E545FF5F-ECF2-4F0C-9FD1-E5E9D63A36A8Q43710081-CD0C3424-2C8E-4C83-BAE4-EAF34ED3D67FQ44400086-9CADF361-456F-4201-8B00-887A1CA47909Q44460295-2819B8C3-9C91-4184-9783-888F03B73DA5Q44969227-C5E9DCB7-A58C-44BC-B386-9588ADEF33A5Q45019942-2C02FB49-6998-46EB-9B31-156985F1FCDDQ46147111-CAD97EB2-5CB9-440F-AC1E-AB37AE3693EAQ46495611-C0945A5C-5BB7-4BBF-86A7-40B039591106Q46667803-89A4A76E-685C-4FCC-9881-7EB7E6195509Q46728947-01172A29-98D2-4BFF-B4F3-33489F03DB70Q46952869-D26380A9-EC29-40E3-85D9-5A0F7D11EB90Q47639668-606BC9B7-21D1-4CCB-911B-6339BA9E8913Q47722027-788FF071-C5DE-4E8C-AD80-AE722A952830Q47970975-5D9E17CD-8DCE-41D7-BCBA-5339B0A1C407Q51073202-C26A2B30-83E1-4FAE-8119-9537C0D7A9AE
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Patrick Berger
@ast
Patrick Berger
@en
Patrick Berger
@es
Patrick Berger
@nl
Patrick Berger
@sl
type
label
Patrick Berger
@ast
Patrick Berger
@en
Patrick Berger
@es
Patrick Berger
@nl
Patrick Berger
@sl
prefLabel
Patrick Berger
@ast
Patrick Berger
@en
Patrick Berger
@es
Patrick Berger
@nl
Patrick Berger
@sl
P214
P1053
D-8779-2012
P106
P21
P214
P31
P3829
P496
0000-0003-4702-0343
P734
P735
P7859
viaf-201994390